论文部分内容阅读
目的:探究抗甲状腺药物对131I治疗甲亢疗效的影响。方法:选取我院2013年5月-2014年7月期间收治的114例甲亢患者,并将其分为给药组、停药组以及非给药组,每组患者为38例,对三组患者的临床治疗效果进行对比。结果:通过治疗后,非给药组的治疗效果明显好于另两组,比较甲状腺激素FT3以及FT4水平,其非给药组的水平好于其他两组,三组间经比较差异显著,具有统计学意义(P<0.05)。结论:抗甲状腺药物减轻了131I的临床治疗效果,所以在临床治疗中,应选取适当的方案进行治疗。
Objective: To investigate the effect of antithyroid drugs on the therapeutic effect of 131I on hyperthyroidism. Methods: A total of 114 patients with hyperthyroidism who were treated in our hospital from May 2013 to July 2014 were selected and divided into three groups: administration group, withdrawal group and non-administration group, 38 patients in each group, The clinical effect of the patients were compared. Results: After treatment, the non-treatment group was significantly better than the other two groups, comparing thyroid hormone FT3 and FT4 levels, the level of non-medication group was better than the other two groups, the difference was significant among the three groups, with Statistical significance (P <0.05). Conclusions: Antithyroid drugs relieve the clinical effect of 131I, so in the clinical treatment, appropriate programs should be selected for treatment.